Paper41998137
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
Tang R and 13 others. EMBO Mol Med, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity. Papers, record 41998137. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41998137
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cancer Vaccines | Major topic |
| Antigens, Neoplasm | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Immunotherapy | |
| Killer Cells, Natural | |
| Mice, Inbred C57BL | |
| Female | |
| Cell Line, Tumor |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U22A20328/82572108/82573538 | the National Natural Science Foundation of China | PubMed | ||
| 2024Y9418/2024Y9420 | Fujian Provincial Joint Foundation for Science and Technology Innovation | PubMed | ||
| 2022Y2018 | Clinical Research Center for Infectious Diseases of Fujian Province | PubMed | ||
| 2022ZQNZD014/2024ZD01004 | the Major Research Projects for Young and Middle-aged Talent of Fujian Provincial Health Commission | PubMed |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25858804 | Immune checkpoint blockade: a common denominator approach to cancer therapy. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25858804 | PubMed |
| 2 | 41286513 | A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial. | Nat Med | 2025 | https://conductscience.org/library/papers/41286513 | PubMed |
| 3 | 31821442 | Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer. | J Exp Med | 2020 | https://conductscience.org/library/papers/31821442 | PubMed |
| 4 | 28976923 | TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis. | Vaccines (Basel) | 2017 | https://conductscience.org/library/papers/28976923 | PubMed |
| 5 | 11323673 | The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. | Nature | 2001 | https://conductscience.org/library/papers/11323673 | PubMed |
| 6 | 28501509 | Designer outer membrane vesicles as immunomodulatory systems - Reprogramming bacteria for vaccine delivery. | Adv Drug Deliv Rev | 2017 | https://conductscience.org/library/papers/28501509 | PubMed |
| 7 | 19109134 | Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein. | J Immunol | 2009 | https://conductscience.org/library/papers/19109134 | PubMed |
| 8 | 35133159 | Neoantigen Immunotherapeutic-Gel Combined with TIM-3 Blockade Effectively Restrains Orthotopic Hepatocellular Carcinoma Progression. | Nano Lett | 2022 | https://conductscience.org/library/papers/35133159 | PubMed |
| 9 | 17325197 | Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. | J Exp Med | 2007 | https://conductscience.org/library/papers/17325197 | PubMed |
| 10 | 22237626 | Exploiting the mutanome for tumor vaccination. | Cancer Res | 2012 | https://conductscience.org/library/papers/22237626 | PubMed |
| 11 | 23890059 | Oncology meets immunology: the cancer-immunity cycle. | Immunity | 2013 | https://conductscience.org/library/papers/23890059 | PubMed |
| 12 | 22596238 | The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer. | Br J Cancer | 2012 | https://conductscience.org/library/papers/22596238 | PubMed |
| 13 | 28187290 | Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. | Cell | 2017 | https://conductscience.org/library/papers/28187290 | PubMed |
| 14 | 29017836 | Emerging Insights into Noncanonical Inflammasome Recognition of Microbes. | J Mol Biol | 2018 | https://conductscience.org/library/papers/29017836 | PubMed |
| 15 | 30307368 | High-resolution glycosylation site-engineering method identifies MICA epitope critical for shedding inhibition activity of anti-MICA antibodies. | MAbs | 2019 | https://conductscience.org/library/papers/30307368 | PubMed |
| 16 | 34447945 | Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity. | Nat Cancer | 2020 | https://conductscience.org/library/papers/34447945 | PubMed |
| 17 | 18394936 | NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. | Immunity | 2008 | https://conductscience.org/library/papers/18394936 | PubMed |
| 18 | 29599246 | Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity. | Science | 2018 | https://conductscience.org/library/papers/29599246 | PubMed |
| 19 | 32103006 | c-FLIP is crucial for IL-7/IL-15-dependent NKp46+ ILC development and protection from intestinal inflammation in mice. | Nat Commun | 2020 | https://conductscience.org/library/papers/32103006 | PubMed |
| 20 | 33536615 | IgA transcytosis and antigen recognition govern ovarian cancer immunity. | Nature | 2021 | https://conductscience.org/library/papers/33536615 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GSDMD | 79792 | PubTator's text mining | https://conductscience.org/library/genes/79792 | NCBI Gene |
| GZMA | 3001 | PubTator's text mining | https://conductscience.org/library/genes/3001 | NCBI Gene |
| GZMB | 3002 | PubTator's text mining | https://conductscience.org/library/genes/3002 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41998137
GET https://conductscience.org/api/papers/v1/41998137/references?page=2